148 related articles for article (PubMed ID: 36539334)
1. Reassessment of Critical Anti-D Antibody Titer in RhD Alloimmunized Antenatal Women.
Singh B; Chaudhary R; Katharia R
Lab Med; 2023 Jul; 54(4):429-433. PubMed ID: 36539334
[TBL] [Abstract][Full Text] [Related]
2. Determination of fetal RHD type in plasma of RhD negative pregnant women.
Sørensen K; Kjeldsen-Kragh J; Husby H; Akkök ÇA
Scand J Clin Lab Invest; 2018 Sep; 78(5):411-416. PubMed ID: 29869532
[TBL] [Abstract][Full Text] [Related]
3. Receipt of RhD-positive whole blood for life-threatening bleeding in female children: A survey in alloimmunized mothers regarding minimum acceptable survival benefit relative to risk of maternal alloimmunization to anti-D.
Sherwood MR; Clayton S; Leeper CM; Yazer M; Moise KJ; Granger ME; Spinella PC
Transfusion; 2024 May; 64 Suppl 2():S100-S110. PubMed ID: 38563495
[TBL] [Abstract][Full Text] [Related]
4. A curious case of anti-D antibody titer.
Hensley JG; Coughlin KP; Klein LL
J Midwifery Womens Health; 2009; 54(6):497-502. PubMed ID: 19879523
[TBL] [Abstract][Full Text] [Related]
5. Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice.
Kent J; Farrell AM; Soothill P
BMC Pregnancy Childbirth; 2014 Feb; 14():87. PubMed ID: 24568571
[TBL] [Abstract][Full Text] [Related]
6. High-throughput non-invasive prenatal testing for fetal rhesus D status in RhD-negative women not known to be sensitised to the RhD antigen: a systematic review and economic evaluation.
Saramago P; Yang H; Llewellyn A; Walker R; Harden M; Palmer S; Griffin S; Simmonds M
Health Technol Assess; 2018 Mar; 22(13):1-172. PubMed ID: 29580376
[TBL] [Abstract][Full Text] [Related]
7. Effect of Anti-D titers in RhD-negative pregnant women on fetuses and newborns: A retrospective study.
Tang TH; Guo CY; Li XY; Hu YX; Liu WK; Yu MX
Pediatr Neonatol; 2024 May; 65(3):288-292. PubMed ID: 37957047
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive Antenatal Screening for Fetal RHD in RhD Negative Women to Guide Targeted Anti-D Prophylaxis.
Clausen FB; Rieneck K; Krog GR; Bundgaard BS; Dziegiel MH
Methods Mol Biol; 2019; 1885():347-359. PubMed ID: 30506209
[TBL] [Abstract][Full Text] [Related]
9. Screening of RHD fetal genotype in RhD negative women.
Kratochvílová T; Böhmová J; Durdová V; Vodička R; Holusková I; Langová K; Lubušký M
Ceska Gynekol; 2020; 85(3):156-163. PubMed ID: 33562966
[TBL] [Abstract][Full Text] [Related]
10. Targeted antenatal anti-D prophylaxis program for RhD-negative pregnant women - outcome of the first two years of a national program in Finland.
Haimila K; Sulin K; Kuosmanen M; Sareneva I; Korhonen A; Natunen S; Tuimala J; Sainio S
Acta Obstet Gynecol Scand; 2017 Oct; 96(10):1228-1233. PubMed ID: 28718198
[TBL] [Abstract][Full Text] [Related]
11. Immunological principle of development of red blood cell alloimmunization in pregnancy, hemolytic disease of the fetus and prevention of RhD alloimmunization in RhD negative women.
Roubalová L; Lubušký M
Ceska Gynekol; 2020; 85(6):408-416. PubMed ID: 33711901
[TBL] [Abstract][Full Text] [Related]
12. Reassessing critical maternal antibody threshold in RhD alloimmunization: a 16-year retrospective cohort study.
Walsh CA; Doyle B; Quigley J; McAuliffe FM; Fitzgerald J; Mahony R; Higgins S; Carroll S; McParland P
Ultrasound Obstet Gynecol; 2014 Dec; 44(6):669-73. PubMed ID: 24706487
[TBL] [Abstract][Full Text] [Related]
13. Targeted antenatal anti-D prophylaxis for RhD-negative pregnant women: a systematic review.
Runkel B; Bein G; Sieben W; Sow D; Polus S; Fleer D
BMC Pregnancy Childbirth; 2020 Feb; 20(1):83. PubMed ID: 32033599
[TBL] [Abstract][Full Text] [Related]
14. Practices for RhD alloimmunization prevention: a vignette-based survey of midwives.
Jourdren G; Berveiller P; Rousseau A
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7629-7639. PubMed ID: 34433367
[TBL] [Abstract][Full Text] [Related]
15. [Spontaneous antepartal RhD alloimmunization].
Studničková M; Holusková I; Durdová V; Kratochvílová T; Strašilová P; Marková I; Lubušký M
Ceska Gynekol; 2015 Dec; 80(6):401-4. PubMed ID: 26741153
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands.
de Haas M; Thurik FF; van der Ploeg CP; Veldhuisen B; Hirschberg H; Soussan AA; Woortmeijer H; Abbink F; Page-Christiaens GC; Scheffer PG; Ellen van der Schoot C
BMJ; 2016 Nov; 355():i5789. PubMed ID: 27821701
[TBL] [Abstract][Full Text] [Related]
17. Anti-D in a mother, hemizygous for the variant RHD*DNB gene, associated with hemolytic disease of the fetus and newborn.
Quantock KM; Lopez GH; Hyland CA; Liew YW; Flower RL; Niemann FJ; Joyce A
Transfusion; 2017 Aug; 57(8):1938-1943. PubMed ID: 28639307
[TBL] [Abstract][Full Text] [Related]
18. A clinical service in the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma.
Finning K; Martin P; Daniels G
Ann N Y Acad Sci; 2004 Jun; 1022():119-23. PubMed ID: 15251949
[TBL] [Abstract][Full Text] [Related]
19. A new biosensor for noninvasive determination of fetal RHD status in maternal blood of RhD negative pregnant women.
Dündar Yenilmez E; Kökbaş U; Kartlaşmış K; Kayrın L; Tuli A
PLoS One; 2018; 13(6):e0197855. PubMed ID: 29874251
[TBL] [Abstract][Full Text] [Related]
20. Routine noninvasive prenatal screening for fetal Rh D in maternal plasma-A 2-year experience from a single center in Belgium.
Blomme S; Nollet F; Rosseel W; Bogaard N; Devos H; Emmerechts J; Cauwelier B
Transfusion; 2022 May; 62(5):1103-1109. PubMed ID: 35352833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
